4//SEC Filing
Mohindru Mani 4
Accession 0001209191-19-033517
CIK 0001346830other
Filed
May 29, 8:00 PM ET
Accepted
May 30, 6:17 PM ET
Size
8.2 KB
Accession
0001209191-19-033517
Insider Transaction Report
Form 4
Mohindru Mani
CFO & Chief Strategy Officer
Transactions
- Award
Common Stock
2019-05-28+8,333→ 16,359 total - Sale
Common Stock
2019-05-29$21.39/sh−2,496$53,389→ 13,863 total
Footnotes (4)
- [F1]Represents the number of shares that vested under a performance-based restricted stock unit award (the "RSU") based on the Issuer's satisfaction of certain performance criteria of the award. In light of the performance-based vesting conditions of the award, such shares were not reportable under Section 16 until vesting was determined, which occurred on May 28, 2019. The vested shares represent one-third of the total number of shares subject to the award, and the remaining shares subject to the award will vest only upon the satisfaction of additional performance vesting criteria. Each RSU represents the contingent right to receive one share of common stock of the Issuer.
- [F2]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting and of the RSUs reported herein as described in greater detail in footnote (1), and does not represent a discretionary trade by the Reporting Person.
- [F3]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding as described in footnote (2).
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.30 to $21.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001664708
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 6:17 PM ET
- Size
- 8.2 KB